This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) slid 3.30% to $6.75 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.30% to 4,300.46 and Dow Jones Industrial Average falling 0.94% to 34,002.92. This was the stock's second consecutive day of losses. Ocugen Inc. closed $12.02 below its 52-week high ($18.77), which the company achieved on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Adverum Biotechnologies Inc. (ADVM) rose 10.09% to $2.40, Ocular Therapeutix Inc. (OCUL) fell 5.59% to $9.79, and Kodiak Sciences Inc. (KOD) rose 1.54% to $98.49. Trading volume (8.1 M) remained 4.1 million below its 50-day average volume of 12.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 4, 2021.
(END) Dow Jones Newswires
October 04, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.